These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 1816645)

  • 1. [Frequency of HIV positivity in donors. Follow-up of ambiguous Western blots].
    Padrón F; Ortiz de Lejarazu R; Eirós JM; Ortiz V
    Sangre (Barc); 1991 Oct; 36(5):436-8. PubMed ID: 1816645
    [No Abstract]   [Full Text] [Related]  

  • 2. [The seroepidemiology of infection with the human immunodeficiency virus type 2 (HIV-2) in Spain (1990). The Spanish Group for the Study and Follow-up of HIV-2 Infection].
    Soriano V; Leal M; Fernández JL
    Med Clin (Barc); 1992 Feb; 98(4):152-4. PubMed ID: 1552768
    [No Abstract]   [Full Text] [Related]  

  • 3. [Significance of seropositivity and problems linked to the identification of seropositive persons].
    Fara GM; Guasticchi G
    Nuovi Ann Ig Microbiol; 1988; 39(4-5):343-5. PubMed ID: 3254488
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of two serological tests for the identification of recent HIV infection: Vironostika HIV-1 Microelisa and BED capture enzyme immunoassay.
    Romero A; Martró E; González V; Matas L;
    Enferm Infecc Microbiol Clin; 2011; 29(7):553-5. PubMed ID: 21501904
    [No Abstract]   [Full Text] [Related]  

  • 5. High rates of HIV seropositivity in Africa--alternative explanation.
    Papadopulos-Eleopulos E; Turner VF; Papadimitriou JM; Alfonso H; Page BA; Causer D; Mhlongo S; Fiala C; Brink A
    Int J STD AIDS; 2003 Jun; 14(6):426-7. PubMed ID: 12816672
    [No Abstract]   [Full Text] [Related]  

  • 6. [Follow-up study of anti-HIV reactive blood donors].
    Caspari G; Beyer J; Schunter F; Knüver-Hopf J; Schmitt H
    Beitr Infusionsther; 1988; 21():153-6. PubMed ID: 2462966
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening of blood donors for antibody to human immunodeficiency virus type 1.
    Acquaye JK
    West Afr J Med; 1993; 12(2):93-5. PubMed ID: 8398939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The serological exam for the human immunodeficiency virus (HIV) as part of the premarital exams].
    Izazola Licea JA; Sánchez Pérez HJ; del Río Chiriboga C
    Gac Med Mex; 1992; 128(3):317-27. PubMed ID: 1302741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detecting recent human immunodeficiency virus type 1 infection: why and how?
    Dobbs T; Parekh BS
    MLO Med Lab Obs; 2003 May; 35(5):12-4, 16, 19-20 passim; quiz 24-5. PubMed ID: 12774433
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of a rapid assay system, HIV 1/HIV 2 Testpack, Abbott, to detect human immunodeficiency virus antibodies in postmortem blood.
    Zehner R; Bratzke H; Mebs D
    J Forensic Sci; 1995 Jan; 40(1):113-5. PubMed ID: 7876792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decisions on screening for viral markers in blood donors.
    Zuck TF
    Dev Biol Stand; 1993; 81():91-100. PubMed ID: 8174824
    [No Abstract]   [Full Text] [Related]  

  • 12. [AIDS and blood transfusion].
    Baumgarten K
    Z Hautkr; 1990 Jul; 65(7):677-80, 683. PubMed ID: 2399757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevalence of anti-HIV-2 antibodies in a population at risk attending the drug-dependence center of the Rho hospital].
    Albert F; Corazza M; Rotondi L; Segrè C
    Boll Ist Sieroter Milan; 1989; 68(2):122-6. PubMed ID: 2577476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV antibody screening among immigrants: a cost-benefit analysis.
    Zowall H; Fraser RD; Gilmore N; Deutsch A; Grover S
    CMAJ; 1990 Jul; 143(2):101-7. PubMed ID: 2114210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of recent HIV-1 infection by a line immunoassay for HIV-1/2 confirmation.
    Schüpbach J; Gebhardt MD; Tomasik Z; Niederhauser C; Yerly S; Bürgisser P; Matter L; Gorgievski M; Dubs R; Schultze D; Steffen I; Andreutti C; Martinetti G; Güntert B; Staub R; Daneel S; Vernazza P
    PLoS Med; 2007 Dec; 4(12):e343. PubMed ID: 18052604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of infection with human immunodeficiency virus in Cuba.
    Molinert HT; Galbán García E; Rodríguez Cruz R
    Bull Pan Am Health Organ; 1989; 23(1-2):62-7. PubMed ID: 2720258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unlinked anonymous screening of antenatal patients for antibody to human immunodeficiency virus type 1 (HIV-1).
    Chew CB; Downie JC; Cunningham AL
    Med J Aust; 1994 Jun; 160(11):693-6. PubMed ID: 8202003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The presence or absence of gp120/gp160 bands on indeterminate western blots: predictive value for HIV seroconversion.
    King R; Frey S; Beisha R; Van de Perre P; Karita E; Allen S
    AIDS; 1993 Mar; 7(3):437-8. PubMed ID: 8471210
    [No Abstract]   [Full Text] [Related]  

  • 19. Routine HIV screening, Part 2: beyond testing and referral.
    Gallant JE
    AIDS Read; 2009; 19(6):211-2. PubMed ID: 19642238
    [No Abstract]   [Full Text] [Related]  

  • 20. [AIDS and HIV infection in the Federal Islamic Republic of Comores (1988-1995)].
    Toyb M; Lombart JP; Binti Abdou A; Oumadi A; Molines C; Josse R
    Med Trop (Mars); 1997; 57(1):59-61. PubMed ID: 9289612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.